SecBot SecBot
6-K ·Filed Jun 9, 2026

IVEVF

Inventiva S.A.
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago SEC0001171843-26-004003
Notable filing: 6-K
Actionable Insight • Neutral

This is a procedural filing with no immediate trading catalyst. Monitor the shareholder vote on June 30, 2026, as approval of the EIB Transactions could reduce warrant overhang and simplify the capital structure. The recent $120 million equity offering (June 2, 2026) and ongoing NATiV3 trial remain the primary drivers.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
IVEVF ▼ -32.65% at T+60d
NEUTRAL call -32.65% · α vs SPY -39.50% · entry $5.33 → $3.59
Entry = T+0 close
Jun 9, 2026
via day close
T+1d
0.00%
call 0.00% · α -1.70%
$5.33
settled 5mo ago
T+5d
-32.65%
call -32.65% · α -34.79%
$3.59
settled 4mo ago
T+20d
-32.65%
call -32.65% · α -36.53%
$3.59
settled 4mo ago
T+60d
-32.65%
call -32.65% · α -39.50%
$3.59
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Inventiva S.A. filed a 6-K announcing the availability of preparatory documents for its Combined General Meeting on June 30, 2026. The meeting includes a 39th resolution related to the EIB Transactions, involving a €50 million repurchase of EIB warrants and issuance of new warrants, subject to shareholder approval. This is a routine procedural filing with no new material financial or operational data.

Key Facts

  • Combined General Meeting scheduled for June 30, 2026 at 2 p.m. in Paris.
  • Agenda includes a 39th resolution regarding the EIB Transactions: repurchase and cancellation of EIB Tranche A Warrants and a portion of Tranche B Warrants for an aggregate repurchase price of €50 million.
  • New EIB Warrants will be issued on more standard terms in substitution for remaining Tranche B Warrants, subject to shareholder approval.
  • Ceilings for resolutions 33-35 (free share grants, stock options, subscription warrants) have been adjusted.
  • Preparatory documents are available on the company's website and at its registered office.

Financial Impact

€50 million aggregate repurchase price for EIB warrants, but no new financial data or operational results disclosed in this filing.

dilutiondebt

Risk Factors

  • Shareholder approval of the EIB Transactions is not guaranteed; failure could delay warrant restructuring.
  • The company remains a clinical-stage biotech with no approved products and significant cash burn.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-004003
Document: f6k_060926.htm0001171843-26-004003
Document: 0001171843-26-004003-index-headers.html0001171843-26-004003
Document: 0001171843-26-004003-index.html0001171843-26-004003
Document: 0001171843-26-004003.txt0001171843-26-004003
7 reports for IVEVF
Performance horizon
67% Hit rate @ T+60 2 of 3 directional calls Went positive at some point 2 of 3 best @ T+60▲ +34.73%Apr 8, 2026
Filters
Rows
Reports for IVEVF — sortable, filterable
TypeNow
Jun 9, 2026
19w ago
6-K
NEUTRAL ★ 3/10
$5.33 $3.59▼ −32.65%▼ −39.50%$3.18 (−40.34%)
Jun 3, 2026
20w ago
6-K
NEUTRAL ★ 2/10
$5.33 $3.59▼ −32.65%▼ −35.14%$3.18 (−40.34%)
Jun 2, 2026
20w ago
6-K
BULLISH ★ 7/10
$5.33 $3.59▼ −32.65%▼ −35.14%$3.18 (−40.34%)
May 26, 2026
21w ago
6-K
NEUTRAL ★ 4/10
$5.33 $3.59▼ −32.65%▼ −34.52%$3.18 (−40.34%)
May 22, 2026
22w ago
6-K
BEARISH ★ 6/10
$5.33 $3.59▲ +32.65%▲ +35.37%$3.18 (+40.34%)
Apr 8, 2026
28w ago
20-F
BEARISH ★ 6/10
$5.50 $3.59▲ +34.73%▲ +45.18%$3.18 (+42.18%)
Mar 30, 2026
30w ago
6-K
MIXED ★ 6/10
$5.50 $3.59▼ −34.73%▼ −47.11%$3.18 (−42.18%)
Showing 7 of 7

US Market Status

Market Closed — Opens Wed (12h 42m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 9, 2026